Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2022 ∙ Federspiel, J. M. Ramsthaler, F. Kettner, M. Mall, G.

Diagnostics of messenger ribonucleic acid (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) vaccination-associated myocarditis—A systematic review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Cardoso Pinto, A. M. Ranasinghe, L. Dodd, P. J. Budhathoki, S. S. Seddon, J. A. Whittaker, E.

Disruptions to routine childhood vaccinations in low- and middle-income countries during the COVID-19 pandemic: A systematic review

  • Newborn
  • Children
  • Low and Middle Income Countries
  • Hepatitis B
  • Poliomyelitis
  • Diphtheria
  • Pertussis
  • Tetanus
  • Haemophilus influenzae type B
  • Pneumococcal disease
  • Rotavirus
  • Measles
  • Human papillomavirus (HPV)
  • Rubella
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Argyris, Y. A. Nelson, V. R. Wiseley, K. Shen, R. Roscizewski, A.

Do Social Media Campaigns Foster Vaccine Adherence? A Systematic Review of Prior Intervention-Based Campaigns on Social Media

  • Americas
  • United States of America
  • Adolescents
  • Adults
  • Older adults
  • Pregnant women
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Paul, S. Mishra, C. M.

Do we need to vaccinate every child against COVID-19: What evidence suggests-A systematic review of opinions

  • Children
  • Adolescents
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Gan, L. Chen, Y. Tan, J. Wang, X. Zhang, D.

Does potential antibody-dependent enhancement occur during SARS-CoV-2 infection after natural infection or vaccination? A meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Eiden, A. L. Barratt, J. Nyaku, M. K.

Drivers of and barriers to routine adult vaccination: A systematic literature review

  • Adults
  • Older adults
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Baier, E. Olgemöller, U. Biggemann, L. Buck, C. Tampe, B.

Dual-Positive MPO-and PR3-ANCA-Associated Vasculitis Following SARS-CoV-2 mRNA Booster Vaccination: A Case Report and Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Feikin, Daniel R. Higdon, Melissa M. Abu-Raddad, Laith J. Andrews, Nick Araos, Rafael Goldberg, Yair Groome, Michelle J. Huppert, Amit O'Brien, Katherine L. Smith, Peter G. Wilder-Smith, Annelies Zeger, Scott Deloria Knoll, Maria Patel, Minal K.

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Addo, I. Y. Dadzie, F. A. Okeke, S. R. Boadi, C. Boadu, E. F.

Duration of immunity following full vaccination against SARS-CoV-2: a systematic review

  • All age groups
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Buonsenso, D. Cusenza, F. Passadore, L. Bonanno, F. De Guido, C. Esposito, S.

Duration of immunity to SARS-CoV-2 in children after natural infection or vaccination in the omicron and pre-omicron era: A systematic review of clinical and immunological studies

  • Newborn
  • Children
  • Adolescents
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...